Retrospective Analysis of the Indications and Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP), Experience at Tertiary Care Center
DOI:
https://doi.org/10.21649/akemu.v32i1.5929Keywords:
Endoscopic retrograde cholangiopancreatography (ERCP), Choledocolithiasis, complication, common bile ductAbstract
Background: As the population ages, the number of biliary tract diseases also increase leading to increased demand of endoscopic retrograde cholangiopancreatography which is currently has been used more for therapeutic purposes than as diagnostic modality.
Objective: The aim of the study was to analyze the characteristics, indications and outcomes of endoscopic retrograde cholangiopancreatography retrospectively.
Methods: This cross sectional study was conducted in the Medicine and Gastroenterology department of Pakistan Railway Hospital, Rawalpindi from 1st Jan 2022 to 31st Dec 2022 retrospectively. Ethical approval was granted by the hospital ethical committee. The study included data of patients who had undergone elective ERCP procedures. Data was collected from electronic record of hospital and endoscopy room data.
Results: Out of 111 ERCPs performed, 50(45.04%) patients were male and 61(54.95%) were female. The mean age of the patients at presentation was 54.42 ± 14.71 years. The most common indication for ERCP was choledocholithiasis 39 (35.1%), followed by benign biliary stricture 23 (20.7%), and cholecystodocholithiasis 20 (18%). The most common complication was acute pancreatitis 6 (5.4%). Cholangitis occurred in 3 (2.7%) while bleeding and duodenal perforation occurred in only one patient (0.9%) respectively. Mortality was reported in only 1 patient (0.9%).
Conclusion: Our study has revealed that the most common indication was for ERCP is choledocholithias and most common complication is pancreatitis. The indications and outcomes are comparable to local and international studies.
References
1. Ong TZ, Khor JL, Selamat DS, Yeoh KG, Ho KY. Complications of endoscopic retrograde cholangiography in the post-MRCP era: a tertiary center experience. World J Gastroenterol. 2005; 11(33):5209-12. doi: 10.3748/wjg.v11.i33.5209.
2. Saito H, Kadono Y, Shono T, Kamikawa K, Urata A, Nasu J, et al. Endoscopic retrograde cholangiopancreatography for bile duct stones in patients with a performance status score of 3 or 4. World J Gastrointest Endosc. 2022; 14(4):215-25. doi: 10.4253/wjge.v14.i4.215.
3. Kazmi SKH, Khan RSA, Alam L, Saeed F. A year of Endoscopic retrograde cholangiopancreatography (ERCP) at a glance. Indications, Intervensions, Complications. Pak Armed Forces Med J. 2022; 72(2): 555-9. doi: https://doi.org/10.51253/pafmj.v72i2.5675.
4. Forbes N, Koury HF, Bass S, Cole M, Mohamed R, Turbide C, et al. Characteristics and Outcomes of ERCP at a Canadian Tertiary Centre: Initial Results from a Prospective High-Fidelity Biliary Endoscopy Registry. J Can Assoc Gastroenterol. 2020; 4(2):78-83. doi: 10.1093/jcag/gwaa007.
5. Maryam S, Amer K, Wajeeha A. Over view of role of ERCP in hepatobiliary problems and encountered complications in a tertiary care hospital in KPK province. Pak Armed Forces Med J. 2019; 69(5):1094-97.
6. Ugurlu ET. Our experiences in 1000 case single-centre endoscopic retrograde cholangiopancreatography. J Minim Access Surg. 2023; 19(1):85-94. doi:10.4103/jmas.jmas_389_21.
7. Maitin-Casalis N, Neeman T, Thomson A. Protective effect of advanced age on post-ERCP pancreatitis and unplanned hospitalisation. Intern Med J. 2015; 45(10):1020-5. doi:10.1111/imj.12844.
8. Kim JY, Lee HS, Chung MJ, Park JY, Park SW, Song SY, et al. Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis. Yonsei Med J. 2019; 60(5):440-45. doi:10.3349/ymj.2019.60.5.440.
9. Zhu G, Hu F, Wang C. Recent advances in prevention and management of endoscopic retrograde cholangiopancreatography-related duodenal perforation. Wideochir Inne Tech Maloinwazyjne. 2021; 16(1):19-29. doi:10.5114/wiitm.2020.101025.
10. Ali F, Aamir N, Hassan MK, Fakhar-E-Alam, Khan HU, Khan D. Comparison of MRCP and ERCP findings: A retrospective secondary data analysis. J Pak Med Assoc. 2022; 72(2):284-86. doi:10.47391/JPMA.20-721.
11. Nawaz MH, Sarwar S, Nadeem MA. Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis. Pak J Med Sci. 2020; 36(3):426-31. doi:10.12669/pjms.36.3.1804.
12. Zhao C, Dai T, Qian J, Ge Z. Risk Factors and Risk Assessment for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. J Coll Physicians Surg Pak. 2024; 34(4):413-8. doi:10.29271/jcpsp.2024.04.413.
13. Leghari A, Ghazanfar S, Qureshi S, Taj MA, Niaz SK, Quraishy MS. Frequency and risk factors in the post-ERCP pancreatitis in a tertiary care centre. J Coll Physicians Surg Pak. 2013; 23(9):620-4.
14. Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020; 52(2):127–49. doi:10.1055/a-1075-4080.
15. Wada K, Takada T, Kawarada Y, Nimura Y, Miura F, Yoshida M, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepato-Biliary-Pancreat Surg. 2007; 14(1):52–8. doi:10.1007/s00534-006-1156-7.
16. Konsue C, Eurboonyanun C, Ruangwannasak S, Eurboonyanu K, Srisuk T, Satitkarnmanee E. et al. Factors associated with the success rate of endoscopic retrograde cholangiopancreatography with standard technique followed by laparoscopic cholecystectomy in the management of choledocholithiasis: a single-center experience. J Digest Endosc. 2020; 11(2):126-33. doi: https://doi.org/ 10.1055/s-0040-1713540.
17. Amin I, Munir A, Memon ML, Zahra SH, Cheema HMKN, Niaz, H. Management of choledocholithiasis in Pakistan: A comparison of endoscopic retrograde cholangiopancreatography and laparoscopic common bile duct exploration. Biol Clin Sci Res J. 2023 ;2023(1):348. doi:10.54112/bcsrj.v2023i1.348.
18. Gupta N, Poreddy V, Al-Kawas F. Endoscopy in the management of choledocholithisis. Curr Gastroenterol Rep. 2008; 10(2):169–76. doi:10.1007/s11894-008-0039-2.
19. Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, et al. Endoscopic management of common bile duct stones: european society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2019; 51(5):472–91. doi:10.1055/a-0862-0346.
20. Shafiq S, Patil M, Philip M. Mirizzi syndrome: A retrospective analysis of 84 patients from a single center. Int J Gastrointest Interv. 2022;11(1):24-8. doi:10.18528/ijgii210018.
21. Dumonceau JM, Tringali A, Blero D, Deviere J, Laugiers R, Heresbach D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012; 44:277-98. doi:10.1055/s-0031-1291633.
22. Paik WH, Lee TH, Park DH, Choi J-H, Kim S-O, Jang S, et al. EUS-Guided Biliary Drainage Versus ERCP for the Primary Palliation of Malignant Biliary Obstruction: A Multicenter Randomized Clinical Trial. Am J Gastroenterol. 2018; 113(7):987–997. doi:10.1038/s41395-018-0122-8.
23. Parvin S, Islam MS, Majumdar TK, Azam MG, Islam MS, Begum MR, et al. Post-ERCP pancreatitis: Frequency and risk stratification from four tertiary care referral hospitals in South East Asia. Medicine (Baltimore). 2022; 101(34):30216. doi:10.1097/MD.0000000000030271.
24. Chen M, Wang L, Wang Y, Wei W, Yao YL, Ling TS, et al. Risk factor analysis of post-ERCP cholangitis: A single-center experience. Hepatobiliary Pancreat Dis Int. 2018; 17(1):55-8. doi:10.1016/j.hbpd.2018.01.002.
25. Oh HC, El Hajj II, Easler JJ, Watkins J, Fogel EL, McHenry L, et al. Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents. Gut Liver. 2018; 12(2):214-8. doi:10.5009/gnl17204.
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk